Introduction
Survivin is a member of the inhibitor of apoptosis (IAP) gene family containing a single baculovirus IAP repeat (BIR) domain and an extended ÀCOOH terminal a-helical-coiled coil. 1 As its first report in human cancers, 2 survivin has been studied for its antiapoptotic activity and its ability to regulate cell-cycle progression. These properties, together with its extensive expression in both solid and hematological malignancies and the relatively restricted expression in normal adult tissues, have made survivin an ideal molecular target for cancer therapy. 3, 4 During embryogenesis, survivin is expressed ubiquitously. 5 However, homozygous knockout of survivin in mouse embryonic stem cells results in disrupted microtubule formation and polyploidy as well as early embryonic fatality. 6 As a result, its role in embryonic development remains unclear.
In zebrafish, the gene encoding for survivin has undergone duplication into survivin1 (sur1) and survivin2 (sur2). This may endow the duplicated genes with more specific functions. 7 Therefore, in contrast to the mammalian system, knockdown of these genes may result in more restricted phenotype that is compatible with embryonic survival. Furthermore, the zebrafish embryos obtain oxygen from ambient water via simple diffusion and can survive the first few days without a functional circulatory system. These unique properties have enabled us to ascertain the hitherto unknown function of survivin during embryogenesis. We have previously demonstrated that zebrafish sur1 mediates angiogenesis but not hematopoiesis. 8 In this study, we examined the functions of sur2, with special reference to hematopoiesis during embryonic development.
Materials and methods

Zebrafish and morpholinos
Wild-type (WT) zebrafish (Danio rerio) were obtained from local aquarium and were maintained and raised under standard conditions at 28 1C. Embryos are produced by natural spawning. Subsequent staging was consistent with that described by Kimmel et al. 9 Transgenic Tg(gata1:gfp) embryos were used to track the erythroid cell populations. 10 Antisense splice-site morpholino (MO; Gene-Tools, Philomath, OR, USA) was designed to target the intron1-exon2 junction of the sur2 gene (sur2 MO). A random sequence MO was used as a control (Table 1) . Procedures for microinjection, whole mount in situ hybridization (ISH), O-dianisidine staining, terminal transferase dUTP nick-end labeling (TUNEL) and caspase-3 activity assays have been described previously. [11] [12] [13] Amino acids sequences alignment and construction of phylogenetic tree
The amino-acid sequences of survivin homologs in various species were aligned with ClustalW (http://align.genome.jp/). The sequence alignment showing the evolutionary relationship between each survivin was illustrated using BioEdit (version 7.0.5.3). Phylogenetic tree was generated using Neighbourjoining method and evaluated using the bootstrapping technique sampling 500 replicates (MEGA 4.0).
Synthesis of antisense and sense mRNA riboprobe for sur2
The full coding sequence of zebrafish sur2 including the 3 0 -untranslated region (UTR) was amplified by PCR (Table 1 ) from cDNA of 24 h.p.f. embryos and subcloned into pGEM-T vector (pGEM-T Vector Systems, Promega Corporation, Madison, WI, USA). sur2 riboprobes (483 bp) was synthesized from linearized vector containing the insert. Digoxigenin (DIG)-labeled antisense and sense probes were synthesized by SP6 and T7 RNA polymerase, respectively, according to the manufacturer's protocols (Roche Applied Science, Indianapolis, IN, USA). The size and integrity of the synthesized riboprobe was confirmed by RNA formaldehyde gel electrophoresis.
Double in situ hybridization
Wild-type embryos at 24 h.p.f. were fixed with 4% paraformaldehyde (PFA) and dehydrated. After stepwise rehydration, the embryos were incubated in prehybridization buffer (50% formamide, 5 Â SSC, 50 mg/ml heparin, 0.1% Tween-20, 5 mg/ml rRNA in phosphate-buffered saline, PBS) at 65 1C, followed by overnight incubation with DIG-sur2 (or DIG-sur1) and fluorescein-a-embryonic hemoglobin riboprobes at 65 1C. The embryos were washed and incubated with alkaline phosphatase (AP)-conjugated anti-DIG antibody (Roche Molecular Biochemicals) for overnight at 4 1C. Blue color was developed using NBT/BCIP (Roche Molecular Biochemicals) as substrate and the reaction was stopped with 0.5 mM EDTA in phosphate-buffered saline with Tween-20 (PBST). AP was destroyed by washing the stained embryo with 0.1 M glycineHCl, pH 2.2, in PBST for 10 min twice. Background staining was removed by washing the embryos in absolute ethanol with continuous monitoring. After rehydration to PBST, embryos were incubated with AP-conjugated antifluorescein antibody (Roche Molecular Biochemicals) for overnight at 4 1C and red color was developed using SIGMAFAST Fast Red TR/Naphthol AS-MX Tablets (Sigma-Aldrich, Shanghai, China) as substrate.
Cloning and preparation of survivin mRNA for microinjection experiments
The complete coding sequence of sur1 and sur2 was TA-cloned into pGEM-T vector (pGEM-T Vector Systems, Promega) and the orientation of the insert confirmed by PCR (Table 1) . To generate mRNA for microinjection, survivin clones were SalI digested and in vitro transcribed at T7 promoter using the mMessage mMachine Kit (Ambion, Austin, TX, USA) according to the manufacturer's protocol. To increase the stability, the mRNA was polyadenylated by the Poly(A) Tailing Kit (Ambion).
Flow cytometry
Tg(gata1:gfp) embryos at 18 h.p.f. were dechorionated and digested with 0.05% trypsin/EDTA solution (Invitrogen, Carlsbad, CA, USA) for 15 min at 28 1C. The embryos were completely dissociated to single-cell suspension by pipetting. Trypsin digestion was terminated by CaCl 2 (2 mmol/l) and the cellular suspension was filtered through a 40 mm cell strainer (BD Falcon, BD Biosciences Discovery Labware, Bedford, MA, USA). Cells were washed and harvested in PBS with 2% FBS and the percentage of green fluorescent protein (GFP) þ cells were enumerated by flow cytometry (Cytomics FC500, Beckman Coulter, CA, Fullerton, USA). In some experiments, the GFP þ (erythroid) population was gated and the cell-cycle status was examined through DNA content analysis, based on a cell permeable DNA stain (DRAQ5 stain, Biostatus Ltd., Leicestershire, UK).
Real-time quantitative RT-PCR
cDNA from 12 and 18 h.p.f. embryos were reverse transcribed from RNA and quantitative reverse transcription (RT)-PCR (Q-PCR) for various hematopoietic genes was performed using the SYBR green PCR master mix (Applied Biosystems, Foster City, CA, USA). Expression level was presented as fold-change calculated using the comparative C T method as described 12, 13 with b-actin as the internal reference. Primer sequences for Q-PCR were shown in Table 1 .
TUNEL staining and caspase-3 activity assay
Terminal transferase dUTP nick-end labeling staining was performed using the ApopTag Fluorescein Direct In situ Apoptosis Detection Kit (Chemicon International Inc., Temecula, CA, USA). Embryos at 18 and 24 h.p.f. were fixed with 4% PFA and dehydrated before staining. After stepwise rehydration, embryos were digested with proteinase K (10 mg/ml) at room temperature (RT) for 15 min. Afterwards, embryos were fixed with 4% PFA again at RT for 1 h and were washed four times with PBST (15 min each). Thereafter, the embryos were incubated in the equilibration buffer for 1 h at RT followed by the TdT reaction mix at 37 1C overnight. Finally, embryos were washed six times with stop/wash buffer and then six times with PBST before examination under fluorescent microscopy. To further examine if the apoptotic signals were localized to hematopoietic tissues, the TUNEL assay was performed in Tg(gata1:gfp) embryos. After the initial enzymatic reaction, the 
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embryos were incubated overnight at 4 1C with 1:500 mouse anti-DIG antibody (Roche Applied Science) and 1:500 rabbit anti-GFP antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA). Thereafter, they were washed with PBST and incubated with 1:1000 biotinylated anti-rabbit immunoglobulin G (IgG; Dako, Glostrup, Denmark) at 4 1C overnight and washed with PBST again for six times. The embryos were then incubated with 1:1000 FITC-conjugated streptavidin (BD Pharmingen, BD Bioscience, San Jose, CA, USA) and 1:1000 goat anti-mouse IgG Alexa Flour 555 (Invitrogen).
To assay for capsase-3 activity, cell lysate was prepared from embryos at 18 h.p.f. and subsequent analysis was performed as per the manufacturer's protocol (Fluorometric CaspACE Assay System, Promega Corporation).
Treatment with caspase-3 inhibitor
To examine if the effects of sur2 MO on erythropoiesis was mediated by the increase in caspase-3 activity, embryos were incubated with reversible aldehyde CPP32 inhibitor Ac-DEVE-CHO (included in the CaspACE Assay System, Fluorometric, Promega Corporation) solution at 12.5 mmol/l from one-cell stage until 18 h.p.f. Control experiments were setup from the same clutches of embryos exposed to equal concentration of dimethyl sulfoxide.
Statistical analysis
Results were expressed as mean±s.e.m. unless otherwise stated. Comparisons between groups of data were evaluated by Mann-Whitney U and Kruskal-Wallis test where appropriate. P-value of less than 0.05 was considered statistically significant.
Results
sur1 and sur2 are highly conserved over the BIR domain
The zebrafish sur1 and sur2 proteins ( Figure 1a ) shared 56% overall identity to each other and 49 and 48% to human survivin. Their BIR domains, the p34cdc2 phosphorylation 14 site and the cysteine residue important for binding to tubulin 15 were highly conserved. The sequences in zebrafish sur1 (LKKTVDSLTV) and sur2 (MSKTFDELTA) were also very similar to a known nuclear export signal in human survivin (VKKQFEELTL) that is necessary for the cytoplasmic localization of the proteins. 16 Phylogenetic analysis (Figure 1b ) of vertebrate survivins showed that zebrafish sur1 and human sur were distinct from zebrafish sur2, suggesting that the duplication of this gene occurred in the common ancestors of teleosts and tetrapods. As a major genome duplication has occurred in the teleost lineage after its divergence from the tetrapods, 17 additional survivin duplicate may occur in the zebrafish genome.
Expression of sur2 in zebrafish embryos
We performed whole-mount ISH to examine sur2 mRNA expression in zebrafish embryos at 18, 24 and 48 h.p.f. At 18 h.p.f., sur2 was expressed specifically in intermediate cell Dr-Survivin2 ----------------------- mass (ICM) and the developing brain (Figures 2a and b) . At 24 h.p.f., its expression extended to the posterior ICM (Figure 2c) . At 48 h.p.f., expression of sur2 was only detectable in the cephalic region but not along the trunk (Figure 2d) . At 24 h.p.f., sur2 was colocalized with a-embryonic hemoglobin (a-eHb) in the ICM (Figure 2e ). This was in contrast to sur1, which was expressed in the vasculature distinctive from a-eHb ( Figure 2f ). As a control for specific sur2 expression, wholemount ISH with sense sur2 riboprobe was performed, showing absence of nonspecific staining throughout the embryos at various developmental stages (Supplementary Figure 1) .
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Targeting sur2 using antisense morpholino
We next examined the role of sur2 during embryonic development. sur2 MO (3 ng) was injected into embryos at 1-4 cells stage and most embryos (referred herewith Sur2 MO embryos) showed overall normal morphology at 24 and 48 h.p.f. (Figures 3a and b) , despite a mild growth delay in eye and head development. At 6 ng, increasingly number of embryos became severely deformed and died shortly after 48 h.p.f. (unpublished data). Therefore, in all subsequent experiments, sur2 MO was injected at 3 ng. Specific targeting of sur2 was confirmed by RT-PCR and DNA sequencing, showing defective splicing in exon-2 (Figures 3e and f) . The latter resulted in frame-shifting, leading to a sense mutation (methioninevaline) at amino-acid 27 and a stop codon thereafter, thereby disrupting the functional BIR domain of sur2 protein (Figures 3g  and h ), which was important for its antiapoptotic function. 1 
Effects of sur2 knockdown on primitive hematopoiesis
We performed initial study on circulating erythroid cells using O-dianisidine staining. Circulation of Sur2 MO embryos was significantly reduced at the Duct of Curvier at 48 h.p.f. (Figures 4a and b) . To focus on the effects on primitive hematopoiesis, we specifically studied embryos at 18 h.p.f., before the onset of circulation. In particular, sur2 MO (3 ng) was injected into Tg(gata1:gfp) embryos at 1-4 cells stage and erythropoiesis was examined quantitatively by flow cytometry after embryo dissociation. There was a significant reduction of GFP þ population in Sur2 MO embryos (uninjected embryos: 4.49±0.15%; Sur2 MO embryos: 2.22±0.12%, n ¼ 4 experiments using more than 400 embryos in total, P ¼ 0.02; Figures 4c and d) . In contrast, coinjection of two MOs targeting the 5 0 UTR and the ATG of sur1 (3 ng each) had no effects on GFP þ population (4.42±0.18%, n ¼ 4 experiments involving 400 embryos; Figure 4e) .
To demonstrate the specificity of sur2 MO targeting, the embryos were coinjected with sur2 MO and sur2 mRNA (50 pg). showing that sur2 (blue arrowheads) colocalized with a-embryonic hemoglobin (a-eHb, red arrowheads) in the ICM (e), whereas sur1 (blue arrowheads) was expressed in the vasculature distinctive from a-eHb (f).
Functions of survivin2 in zebrafish primitive hematopoiesis ACH Ma et al
This resulted in restoration of GFP þ population to 4.35 ± 0.09% (n ¼ 3 experiments involving 450 embryos in total) (Figure 4f ). Coinjecting the embryos with sur2 MO and sur1 mRNA (30 pg) also resulted in restoration of GFP þ population to 3.85 ± 0.05% (n ¼ 3 experiments involving 450 embryos in total) (Figure 4g ). 
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Sur2-WT NPWSEHAKRSPNCAFLHMSKTFDELTAIEYFHLEQERLRIYIKKMGHRKIAYFRDEVEAT 120 Figures 5k-n) . The results were confirmed quantitatively using Q-PCR in 12 and 18 h.p.f. embryos ( Table 2) . Injection of sur2 MO also resulted in downregulation (albeit modest) of c-myb and runx1 expression (genes associated with definitive hematopoiesis) at 24 h.p.f. whose significance was not further examined in the present study.
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Effects of sur2 knockdown on gene expression associated with brain development
The delayed eye and brain development in Sur2 MO embryos at 48 h.p.f. have also led us to examine the effects of sur2 knockdown on related gene expression at earlier stage of development (18 h.p.f.). Whole-mount ISH showed that neurogenin (ngn) (Figures 5o and p 
MO embryos at 18 h.p.f. The results were also confirmed quantitatively using Q-PCR ( Table 2) .
Effects of sur2 knockdown on apoptosis by TUNEL and caspase-3 activity
We further investigated the effects of sur2 knockdown on apoptosis and tested if the aforementioned effects on hematopoiesis were related to the inhibition of apoptosis. A random sequence MO embryos in each case was based on DC T as described previously. 13 Statistical analysis was evaluated by Student's paired t-test. The data as shown represented average results of four experiments using more than 800 embryos. pu.1, l-plastin, mpo and mgn were not examined at 12 h.p.f. because their low level of expression precluded accurate evaluation. Muscle (mgn) and neural markers (pax2a, egr2b, ngn) were examined at 18 h.p.f. as a control of growth development.
Sur2
Functions of survivin2 in zebrafish primitive hematopoiesis ACH Ma et al MO (3 ng) was used as control for nonspecific toxicity because of MO injection. At 18 h.p.f., specific caspase-3 activity was significantly increased in Sur2 MO embryos (Sur2 MO : 201.9 ± 8.8 vs control: 103.6±3.7 a.u., P ¼ 0.001). To examine the spatial distribution of apoptotic signals in the Sur2 MO embryos, we performed whole-mount TUNEL assay in both Sur2
MO and control embryos. There was significant increase in TUNEL staining in Sur2 MO embryos at the vicinity of ICM (Figures 6a-d) . Colocalization of the TUNEL signal and GFP in Tg(gata1:gfp) embryos clearly showed that the apoptotic cells were located in the ICM (Figures 6e-g ).
To test the hypothesis that the increase in apoptosis in the Sur2
MO embryos was causally related to the decrease in hematopoiesis, the Sur2 MO embryos in the Tg(gata1:gfp) background were treated with a specific caspase-3 inhibitor Ac-DEVD-CHO (12.5 mmol/l) from 0 to 18 h.p.f. It resulted in significant amelioration of the effects of sur2 MO on GFP þ population (control: 4.06 ± 0.06%; Sur2 MO embryos: 2.12±0.09% (compared with control, P ¼ 0.02); Sur2 MO embryos treated with Ac-DEVD-CHO: 3.97 ± 0.05%, (compared with control, P ¼ 0.51); Figures 6h-j).
Discussion
In this study, we demonstrated that sur2 knockdown using antisense MO significantly reduced embryonic hematopoiesis at both stem and lineage-committed cell level. Functions of survivin2 in zebrafish primitive hematopoiesis ACH Ma et al defective splicing of sur2, as well as by successful sur2 mRNA rescue. The reduction of hematopoiesis was associated with an increase in apoptosis in a caspase-dependent fashion. Despite in vitro 18, 19 and in vivo 20 studies showing that disruption of survivin function enhanced apoptosis and reduced adult hematopoiesis, information about its role during embryonic development was lacking. In this respect, our data have shed important light to our understanding of sur2 during development.
We demonstrated the distinctive roles of sur1 and sur2 during embryonic development in zebrafish. In particular, sur1 and sur2 were distinctively expressed in the vasculature and hematopoietic tissues. This was reminiscent of the differential spatial gene expression of survivins in Xenopus. 21 We have previously shown that sur1 mediated angiogenesis in zebrafish embryos. 8 However, hematopoiesis was not affected. The latter was again confirmed in the present study. In addition, we demonstrated unequivocally that sur2 maintained hematopoiesis by virtue of its antiapoptotic activity and the effects were dependent on caspase-3. Intriguingly, the hematopoietic defects in the Sur2 MO embryos could be rescued by sur1 mRNA. These observations suggested that the distinctive roles of sur1 and sur2 during embryonic development may be related to a large extent to their difference in spatial expression.
Moreover, we demonstrated that sur2 exhibited antiapoptotic activity and the increase in apoptosis in the Sur2 MO embryos was restricted to the ICM and colocalized with gata1-expressing cells. This is in marked contrast to Sur1 MO embryos in which increase in apoptosis did not correlate spatially with the defects in angiogenesis. 8 Genes associated with both hematopoietic stem and lineage committed cell development were reduced in Sur2 MO embryos, supporting the proposition that sur2 being important for the maintenance of hematopoiesis at stem and progenitor cell level.
There were limitations in this study. For instance, similar to the sur1 knockdown, 13 the development of eye and brain in Sur2 MO embryos at 24 and 48 h.p.f. was slightly delayed. The phenotype was gene specific and could be rescued by concomitant sur2 mRNA injection (data not shown). However, as it was not associated with any significant changes in gene expression or apoptosis in those regions at 18 h.p.f. and was unlikely to explain the hematopoietic defects in the Sur2 MO embryos, the phenotype was not further examined in the present study. As p53 pathway is commonly activated by MO, leading to necrosis of the head region, 22 it would be worthwhile testing if coinjection of MO targeting at p53 might also rescue the reduced head phenotype. Moreover, despite the substantial increase in apoptosis in the ICM of the Sur2 MO embryos as shown by TUNEL staining, the reduction in erythropoiesis, as demonstrated by both flow cytometry and quantitative PCR, was only about 50%. Whether it reflected a difference in sensitivity of these parameters in detecting the cellular changes resulting from sur2 knockdown or a more complex causal relationship between apoptosis and erythropoiesis would have to be further investigated. Moreover, the profound reduction of O-dianisidine staining in 48 h.p.f. Sur2
MO embryos could be because of the progressive effects of sur2 knockdown at later time point and/or a yet undefined effect on vasculature development. In fact, Sur2
MO embryos might also have defective angiogenesis, which is currently under investigation in our laboratory. These issues would also require further investigations.
Notwithstanding these limitations, results from the present study have provided us with further leads into the study of apoptosis during embryonic hematopoiesis. In particular, we 12 and others 23 have previously reported the role of death receptor in modulating primitive hematopoiesis. Therefore, how the proapoptotic and antiapoptotic signals integrate to regulate embryonic hematopoiesis would warrant further study. Furthermore, the regulation of sur2 during embryonic development would also have to be determined. In cancer model, survivin expression was regulated by vascular endothelial growth factor (VEGF) in a phosphatidylinositol 3-kinase-dependent fashion. 24 In the zebrafish embryos, despite the observations that VEGF inhibitor significantly reduced primitive hematopoiesis 25 and sur2 mRNA expression (data not shown), the phenotype could not be rescued by either WT or phosphorylation mimetic forms of sur2 mRNA (data not shown). Alternative regulatory signals for sur2 expression in zebrafish embryos remain to be further elucidated. 26 
